文献速递系统性红斑狼疮

CD8+CD103+ iTregs通过减轻肾小球内皮细胞损伤抑制狼疮肾炎进展

CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

本研究探讨CD8+CD103+ iTregs减轻肾小球内皮细胞(GEC)损伤以改善狼疮肾炎(LN)的机制。SLE患者Treg频率与VCAM-1和ICAM-1表达呈负相关;过继转移CD8+CD103+ iTregs至MRL/lpr小鼠可降低自身抗体和蛋白尿、减轻肾脏病理病变及IgG/C3沉积。该iTregs还抑制促炎介质表达并通过促进血管生成减轻GEC损伤。

要点

  • SLE患者Treg频率与VCAM-1和ICAM-1表达呈负相关
  • CD8+CD103+ iTregs过继转移降低MRL/lpr小鼠自身抗体、蛋白尿及肾脏IgG/C3沉积
  • CD8+CD103+ iTregs通过促进血管生成减轻GEC损伤

核心结论

  • CD8+CD103+ iTregs通过减轻GEC损伤抑制狼疮肾炎进展,可能用于LN及其他自身免疫病。

研究设计与样本

  • 研究比较SLE患者与健康对照的Treg细胞特征,并在MRL/lpr小鼠中过继转移CD8+CD103+ iTregs。
  • 采用流式细胞术、ELISA、western blot、qRT-PCR及多种组织学和电镜方法分析。

主要发现

  • SLE患者Treg频率与VCAM-1和ICAM-1表达呈负相关。
  • MRL/lpr小鼠过继转移CD8+CD103+ iTregs后自身抗体和蛋白尿水平降低、肾脏病理病变减轻、IgG/C3沉积减少。
  • CD8+CD103+ iTregs抑制促炎介质表达并通过促进血管生成减轻GEC损伤。

临床怎么用

  • CD8+CD103+ iTregs可能作为狼疮肾炎及其他自身免疫病的潜在细胞治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We previously reported that ex vivo TGF-β and IL-2-induced CD8+CD103+ regulatory T cells (CD8+CD103+ iTregs) displayed similar immunosuppressive effect and therapeutic function on lupus mice nephritis to that of CD4+Foxp3+ Tregs. In view of the important role of glomerular endothelial cell (GEC) injury in inflammatory processes in SLE, this study aimed to investigate the nature and mechanism of CD8+CD103+ iTregs-mediated amelioration of LN by attenuating GEC injury. METHODS: Treg cells from patients with SLE and from healthy controls were characterized by flow cytometry analysis. The expression of pro-inflammatory mediators and VEGF were analysed in healthy controls, patients with SLE and MRL/lpr mice by ELISA, western blot, and real-time quantitative RT-PCR (qRT-PCR). Typical lesions of diffuse proliferative LN were observed in MRL/lpr mice through the use of haematoxylin and eosin, Masson, periodic acid-Schiff, periodic acid-Schiff methenamine, transmission electron microscopy and IF microscopy. Angiogenesis was analysed in GECs by cell investigating proliferation, migration, and tube formation. RESULTS: The results revealed that the frequency of Treg cells was inversely correlated with the expression of VCAM-1 and ICAM-1 in patients with SLE. Furthermore, adoptive transfer of CD8+CD103+ iTregs to MRL/lpr mice was associated with decreased levels of autoantibodies and proteinuria, reduced renal pathological lesions, and lowered renal deposition of IgG/C3. We further found that CD8+CD103+ iTregs not only suppressed the expression of pro-inflammatory mediators but also attenuated GEC injury by promoting angiogenesis. CONCLUSION: Our study has identified the role of CD8+CD103+ iTregs on attenuating GEC injury and provided a possible application of this new iTregs subset in lupus nephritis and other autoimmune diseases.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Deng W, Xu M, Meng Q, et al. CD8+CD103+ iTregs inhibit the progression of lupus nephritis by attenuating glomerular endothelial cell injury. Rheumatology (Oxford). 2019. PMID: 31329981. doi:10.1093/rheumatology/kez112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。